IMRT-based optimization approaches for volumetric modulated single arc radiotherapy planning

Radiotherapy and Oncology

Volumn 95, Issue 2, 2010, Pages 149-152

  Crijns, Wouter ^a   Budiharto, Tom ^a   Defraene, Gilles ^a   Verstraete, Jan ^a   Depuydt, Tom ^a   Haustermans, Karin ^a   Van Den Heuvel, Frank ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Dose escalation; Prostate cancer; RapidArc ; VMAT

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; TREATMENT PLANNING; ADENOCARCINOMA; COMPUTER ASSISTED RADIOTHERAPY; INSTRUMENTATION; MALE; METHODOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77956633074     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.01.012     Document Type: Article

References (17)

1. Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:996-1001.
2. Cozzi L, Dinshaw KA, Shrivastava SK, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008;89:180-1.
3. Van den Heuvel F, Fugazzi J, Seppi E, Forman JD. Clinical application of a repositioning scheme, using gold markers and electronic portal imaging. Radiother Oncol 2006;79:94-100.
4. Budiharto T, Slagmolen P, Hermans J, et al. A semi-automated 2D/3D markerbased registration algorithm modelling prostate shrinkage during radiotherapy for prostate cancer. Radiother Oncol 2009;90:331-6.
5. Peeters ST, Lebesque JV, Heemsbergen WD, et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2006;64:1151-61.
6. Michalski JM, Winter K, Purdy JA, et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 2005;62:706-13. (Pubitemid 40779758)
7. Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998;41:83-92. (Pubitemid 28211306)
8. Fiorino C, Fellin G, Rancati T, et al. Clinical and dosimetric predictors of late rectal syndrome after 3 D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 2008;70:1130-7. (Pubitemid 351296107)
9. al Abany M, Helgason AR, Cronqvist AK, et al. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys 2005;61:1035-44. (Pubitemid 40340898)
10. Ling CC, Zhang P, Archambault Y, Bocanek J, Tang G, Losasso T. Commissioning and quality assurance of RapidArc radiotherapy delivery system. Int J Radiat Oncol Biol Phys 2008;72:575-81.
11. Rancati T, Fiorino C, Gagliardi G, et al. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 2004;73:21-32. (Pubitemid 39304121)
12. Guckenberger M, Baier K, Richter A, Vordermark D, Flentje M. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? Radiat Oncol 2008;3.
13. Williams SG, Taylor JM, Liu N, et al. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. Int J Radiat Oncol Biol Phys 2007;68:24-33. (Pubitemid 46589844)
14. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653-6.
15. Van den Heuvel F. Decomposition analysis of differential dose volume histograms. Med Phys 2006;33:297-307. (Pubitemid 43183971)
16. Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009;93:226-33.
17. Guckenberger M, Richter A, Krieger T, Wilbert J, Baier K, Flentje M. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complexshaped target volumes? Radiother Oncol 2009;93:259-65.